INDENTURE (Made as of November 28, 2017 Between AURORA CANNABIS INC. (the “Corporation”) and COMPUTERSHARE TRUST COMPANY OF CANADA (the “Trustee”)Indenture • October 5th, 2018 • Aurora Cannabis Inc • Ontario
AURORA CANNABIS INC. as Borrower - and - THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Lenders - and - BANK OF MONTREAL as Administrative Agent - and - BANK OF MONTREAL as Lead Arranger and Sole BookrunnerCredit Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party, the parties agree as follows:
and CANNIMED THERAPEUTICS INC. SUPPORT AGREEMENT January 24, 2018Support Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
THIS FIRST SUPPLEMENTAL INDENTURE is entered into as of the 25th day of July, 2018.First Supplemental Indenture • October 5th, 2018 • Aurora Cannabis Inc • Ontario
Companies Also Sign Investor Rights AgreementServices Agreement • October 5th, 2018 • Aurora Cannabis Inc
VANCOUVER, Nov. 6, 2017 /CNW/ - Further to the two companies' joint press release of October 23, 2017, Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM)) and Radient Technologies Inc. ("Radient") (TSXV: RTI) today announced the companies have finalized a Master Services Agreement (the "Agreement"), pursuant to which Radient has agreed to perform certain services for Aurora using its proprietary MAP™ technology, as well as other technologies, as an independent contractor in relation to the development, commercialization and supply of standardized cannabis extracts. The Agreement has an initial term of five years, with an option for Aurora to renew the agreement for an additional five years.
ARRANGEMENT AGREEMENTArrangement Agreement • October 5th, 2018 • Aurora Cannabis Inc • British Columbia
with such exceptions, in the case of each of clauses (c)(ii) through (c)(iv), as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect with respect to the ICC Group.
SPECIAL WARRANT INDENTURE Providing for the Issue of Special WarrantsSpecial Warrant Indenture • October 5th, 2018 • Aurora Cannabis Inc
WHEREAS, pursuant to the terms of the Agency Agreement, the Corporation sold an aggregate of 115,000 Special Warrants at the purchase price of $1,000 per Special Warrant;
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • October 5th, 2018 • Aurora Cannabis Inc • British Columbia
Aurora Cannabis Inc. (“Aurora”) is concurrently herewith entering into an arrangement agreement (the “Arrangement Agreement”) with ICC Labs Inc. (“ICC”) which provides for, among other things, the acquisition by Aurora of all of the issued and outstanding common shares (the “Shares”) of ICC by way of a plan of arrangement (the “Plan of Arrangement”) under Section 288 of the Business Corporations Act (British Columbia) (the “BCBCA”) (the “Transaction”). Under the terms of the Arrangement Agreement, Aurora will acquire all of the issued and outstanding Shares at a price per Share of $1.95 payable in such number of common shares in the capital of Aurora (“Aurora Shares”) as is equal to the quotient of $1.95 divided by the volume-weighted average trading price of the Aurora Shares on the Toronto Stock Exchange in the twenty (20) Business Days (as such term is defined in the Arrangement Agreement) preceding the effective date of the Transaction (the last day of such period being the second
SUBSCRIPTION AGREEMENT FOR SUBSCRIPTION RECEIPTSSubscription Agreement • October 5th, 2018 • Aurora Cannabis Inc
The Subscriber acknowledges that the Issuer is not a “reporting issuer” (or equivalent thereof) in any jurisdiction, that the Subscription Receipts, Common Shares, Warrants and Warrant Shares are subject to an indefinite restriction on resale (i.e., a “hold period”) under applicable securities laws and that it will not be able to resell any of the Subscription Receipts, Common Shares, Warrants and Warrant Shares until expiration of the applicable hold period (which hold period will not commence to run until the Issuer has become a “reporting issuer” in a jurisdiction of Canada (which the Issuer has no obligation to become)) other than in accordance with limited exemptions under applicable securities legislation and regulatory policy.
Aurora and Namaste to Complete Strategic Private-Label Software and Patient Referral Agreements TSX: ACB CSE: NAurora Cannabis Inc • October 5th, 2018
EDMONTON and VANCOUVER, Jan. 2, 2018 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Namaste Technologies Inc. ("Namaste") (CSE: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced the signing of a binding term sheet towards a final Private-Label Software Agreement ("Private Label Agreement"), whereby Namaste will provide Aurora's wholly-owned subsidiary, CanvasRx Inc. ("CanvasRx") with a customized version of Namaste's patient acquisition tool, NamasteMD.com ("NamasteMD"), as well as desktop and mobile applications for Google Android and Apple iOS platforms. The companies have 30 days to complete a final agreement.
DEPOSITARY AGREEMENTDepositary Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
Aurora Cannabis Inc. (“Aurora”) and MedReleaf Corp. (“MedReleaf”, and together with MedReleaf, the “Companies”) wish to engage Computershare Investor Services Inc. (“Computershare”) as depositary in connection with a proposed plan of arrangement (the “Arrangement”) involving the Companies under an agreement dated May 14, 2018, as amended by an amending agreement dated May 24, 2018 (the “Arrangement Agreement”).
MASTER SERVICES AGREEMENTInvestor Rights Agreement • October 5th, 2018 • Aurora Cannabis Inc • Alberta
Radient shall store the Input Material and Processed Material in a prescribed manner and in compliance with the terms of the ACMPR and the Quality Agreement.
INVESTOR RIGHTS AGREEMENT AURORA CANNABIS INC. and THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. and ROBERT ANDERSON January 12, 2018 ___________________________Investor Rights Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
WHEREAS the Company and the Investor have entered into a subscription agreement dated January 4, 2018 (the “Subscription Agreement”) whereby the Investor purchased subscription receipts to acquire common shares and warrants of the Company, which when issued would represent approximately 15% of the Company’s issued and outstanding common shares on a fully diluted basis (based on the Company’s outstanding common shares at the issue date);
